No ratings yet
Taught by or worked with Ehsan? Your rating helps other students choose.
Dr. Ehsan Rahimy is Adjunct Clinical Associate Professor of Ophthalmology at Stanford University School of Medicine. He specializes in the medical and surgical management of diseases affecting the retina, with clinical expertise in macular degeneration, diabetic retinopathy, retinal detachment, macular hole, macular pucker/epiretinal membranes, and uveitis. Dr. Rahimy graduated with highest distinction from the University of Michigan and received his medical degree with high honors from Baylor College of Medicine, where he was inducted into the Alpha Omega Alpha Honor Society. He completed ophthalmology residency at the Jules Stein Eye Institute at UCLA, receiving the Pepose-Saltzman Young Investigator Research Award, Henry & Lilian Nesburn Research Award, and Devgan Outstanding Surgical Resident Award. He then pursued subspecialty training in vitreoretinal surgery at Wills Eye Hospital, where he received the Heed Fellowship, Ronald G. Michels Fellowship Award, and William B. Tasman Outstanding Fellow Award.
Dr. Rahimy has authored well over 100 peer-reviewed publications, numerous book chapters, and other literature, and has contributed over 200 conference abstracts presented at national and international meetings. He is frequently invited to speak at such meetings and is consulted for collaborative research. He advises early-stage companies in ophthalmology, telemedicine, artificial intelligence, and medtech innovation. His honors include the Distinguished Fellow Award from the American Society of Retina Specialists in 2021, Achievement Award from the American Academy of Ophthalmology in 2019, election to the Retina Society in 2019, and multiple other awards from the American Society of Retina Specialists.
Explore the Stanford study showing colorblindness masks blood in urine, raising bladder cancer death risk by 52%. Learn symptoms, advice, and research implications.
Explore the Stanford study revealing how colorblindness delays bladder cancer detection via missed hematuria, leading to 52% higher mortality. Insights on risks, stats, and prevention.
Photo by Antoine Dautry on Unsplash
Photo by Chris Liverani on Unsplash
Photo by Peter Burdon on Unsplash
Photo by Andrii Zhuk on Unsplash
Photo by EESOFUFFZICH on Unsplash
Photo by Google DeepMind on Unsplash
Photo by Gabriele Malaspina on Unsplash
